#SFHS2606937ADecree of 31 March 2026 on the conditions for the coverage of pharmaceutical specialties with marketing authorization listed in the list referred to in Article L. 5126-6 of the Public Health Code
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
This decree updates the official list of reimbursable pharmaceutical products in French hospitals. It specifically changes the Unique Coding for Dispensing (UCD) identifier for the specialty ZUTECTRA 500UI INJ SRG 1 ML. The previous code is replaced by the new code 34008 937 367 1 5. This update ensures correct identification and billing for this hepatitis B immunoglobulin product used in hospital settings. The change is technical in nature and maintains the product's eligibility for reimbursement under the existing framework of Article L. 5126-6.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- Replaces the UCD code for ZUTECTRA 500UI INJ SRG 1 ML with 34008 937 367 1 5 in the annex of the 6 March 2026 decree
- Maintains the product's status on the list of reimbursable hospital pharmaceuticals under Article L. 5126-6
- No change to pricing, indications, or conditions of coverage
+ 2 more changes with Pro
Obligations
What this law requires
Replace the UCD (Unique Coding for Dispensing) identifier for the pharmaceutical specialty 'ZUTECTRA 500UI INJ SRG 1 ML' with the new code 34008 937 367 1 5 in the official list of reimbursable products
Update all billing and identification systems to use the new UCD code 34008 937 367 1 5 for ZUTECTRA 500UI INJ SRG 1 ML to ensure correct identification and reimbursement processing
Publish this decree in the Journal officiel de la République française